EXAMPLE FORMAT THAT YOU SHOULD FOLLOW CLOSELY AND CANONICAL TERMS WHICH SHOULD BE REUSED WHEN APPLICABLE:

Dopamine and norepinephrine releasing agent
- Amphetamine
- Dextroamphetamine
- Methamphetamine
- Adderall (Addy, Dextroamphetamine+Amphetamine)
- Adderall XR
- Lisdexamfetamine (Vyvanse)
- Benzphetamine
- Clobenzorex
- Amfecloral
- 2-Fluoroamphetamine (2-FA)
- 2-Fluoroethamphetamine (2-FEA)
- 2-FMA (2-Fluoromethamphetamine)
- 3-CAF (3-chloroamphetamine)
- 2-Methylamphetamine (2-MA, Ortetamine)
- 3-Fluoroamphetamine (3-FA, PAL-353)
- 3-Fluoroethamphetamine (3-FEA)
- 3-Fluoromethamphetamine (3-FMA)
- 4-Methylephedrine
- Dextromethamphetamine (Desoxyn)
- Amfepramone (Diethylpropion)
- Ephedrine

Serotonin, dopamine, and norepinephrine releasing agent
- MDMA
- 2-Bromo-4,5-MDMA
- Mephedrone (4-MMC)
- 5-APB
- 6-APB
- 2-MAPB
- 5-MAPB
- 5-MAPDB
- 5-EAPB
- 5-AEDB
- Aminorex
- 3-Methylaminorex (3-MAR)
- 4-Methylaminorex
- 4,4'-Dimethylaminorex
- 4'-Fluoro-4-methylaminorex
- 4′-Chloro-4-methylaminorex (4C-MAR, 4-Cl-MAR)
- 4B-MAR (4-Bromo Aminorex)
- Fluminorex
- Fenozolone
- 3,4-Methylenedioxyphenmetrazine (MDPM, 3-MDPM)

Serotonin releasing agent
- Fenfluramine
- 4-Bromoamphetamine (PBA, 4-BA)
- 4-Fluoroamphetamine (4-FA, para-fluoroamphetamine, PFA)
- 4-Fluoroethamphetamine (4-FEA)
- 4-Fluoromethamphetamine (4-FMA)
- 5-APDI (5-IAP, IAP)

Dopamine and norepinephrine reuptake inhibitor
- Methylphenidate (MPH)
- Ethylphenidate (EPH)
- Isopropylphenidate (IPPH)
- Serdexmethylphenidate
- 4F-MPH (4-Fluoromethylphenidate)
- 4-Methylmethylphenidate (4-Me-TMP)
- Mazindol
- Pipradrol
- 2-DPMP (Desoxypipradrol)
- Diphenylprolinol (D2PM)
- Bupropion

Serotonin, dopamine, and norepinephrine reuptake inhibitor
- Cocaine
- Cocaethylene
- Crack (Cocaine)
- Naphyrone
- Tesofensine
- 3,3-Diphenylcyclobutanamine (3,3-DPCB)
- Sibutramine

Potent dopamine and norepinephrine reuptake inhibitor
- α-Pyrrolidinopentiophenone (α-PVP, Flakka, Gravel, A-PVP)
- α-Pyrrolidinohexiophenone (a-PHP)
- alpha-PiHP (A-PiHP)
- α-PCYP (alpha-PyrrolidinoCyclohexanoPhenone)
- α-Pyrrolidinopropiophenone
- 4-Fluoro-α-pyrrolidinopropiophenone (4F-PPP)
- 4-Cl-PPP
- 4-Fluoro-alpha-PHP (4F-PHP)
- 3F-PiHP (3-Fluoro-PiHP)
- 2-Me-PiHP
- Methylenedioxypyrovalerone (MDPV)
- MD-PHP
- MD-PiHP
- MD-prolintane
- Prolintane
- Pyrovalerone
- alpha-D2PV (α-D2PV, a-D2PV, 2-Diphenylmethylpyrrolidin-1-ylpentan-1-one)
- 3-Methyl-4-fluoro-α-pyrrolidinovalerophenone
- 3,4-Dimethoxy-α-PHP (DMO-PHP)
- 5-DBFPV

Dopamine and norepinephrine releasing agent 
- Methcathinone

Dopamine and norepinephrine reuptake inhibitor 
- 2-Methylethcathinone
- 2-MMC
- 2-NMC (2'-Propionaphthone)
- 3-CEC (3-Chloroethcathinone)
- 3-Chloromethcathinone (3-CMC)
- 3-Fluoromethcathinone
- 3-Methylethcathinone
- 3-Methylmethcathinone
- 3,4-DMMC (3,4-dimethyl-methcathinone)
- 3,4-Trimethylenepentedrone
- 4-Bromomethcathinone
- 4-CBC (4-Chlorobuphedrone)
- 4-CEC (4-Chloroethcathinone)
- 4-CMC (4-Chloromethcathinone, Clephedrone)
- 4-EEC (4-Ethylethcathinone)
- 4-EMC
- 4-Ethylpentedrone (4-EPD)
- 4-Fluoropentedrone
- 4-MBC (Benzedrone)
- 4-MEC (4-Methylethcathinone)
- 4F-MABP (4-fluorobuphedrone)
- 4-MPD (4-Methylpentedrone)
- Brephedrone
- 5-BPDi
- Hexedrone
- Hexen (N-Ethylhexedrone)

Serotonin releasing and dopamine/norepinephrine reuptake inhibiting agent
- Butylone (βk-MBDB)
- Cyputylone (N-Cyclohexylmethylone)
- Dipentylone
- Dimethylpentylone (N,N-Dimethylpentylone)
- Eutylone
- EDMC (3,4-Ethylenedioxymethcathinone, 3,4-EDMC)
- Flephedrone (4-Fluoromethcathinone, 4-FMC)

Atypical dopamine reuptake inhibitor
- Modafinil
- Armodafinil
- Adrafinil
- Flmodafinil
- Dehydroxyfluorafinil

Dopamine and norepinephrine releasing agent
- 3-Chlorophenmetrazine (3-CPM)
- 3-Fluorophenmetrazine (3-FPM, 3-FPH, PAL-593)
- Phendimetrazine
- Phenmetrazine
- 4-Methylphenmetrazine (4-MPM)

Dopamine and norepinephrine releasing agent
- BZP (Benzylpiperazine)

Serotonin receptor agonist
- 4-Fluorophenylpiperazine

Adrenergic receptor agonist
- Phenylephrine

Indirect adrenergic agonist
- 1,4-DMAA (1,4-dimethylamylamine)
- DMHA (Octodrine)

Nicotinic acetylcholine receptor agonist
- Nicotine

Muscarinic acetylcholine receptor agonist
- Arecoline

Adenosine receptor antagonist
- Caffeine

Dopamine synthesis enhancer
- Bromantane

Trace amine receptor agonist
- Phenethylamine
- Phenylpropylaminopentane

Norepinephrine reuptake inhibitor
- Viloxazine

Dopaminergic stimulant (uncertain mechanism)
- Pemoline

Unclear stimulant mechanism 
- Cyclazodone
- N-Methyl-Cyclazodone (NMC)
- 2-PA
- 2-PTA
- 2-MPPP
- Methyl-K

Combination mechanism
- Phentermine+Fenfluramine (Phen/Fen, Fen-Phen)

Serotonin, dopamine, and norepinephrine releasing agent
- 3,4-Methylenedioxyamphetamine (MDA)

Serotonergic Agonist / Serotonin, dopamine, and norepinephrine releasing agent
- alpha-Methyltryptamine (AMT)

Serotonin releasing agent
- 4-Methylthioamphetamine (4-MTA, MTA)

Gamma-aminobutyric acid type A receptor positive allosteric modulator (benzodiazepine site)
- Alprazolam
- Diazepam (Valium)
- Lorazepam
- Oxazepam
- Temazepam
- 3-Hydroxyphenazepam
- Adinazolam
- Avizafone
- Bromazepam
- Bromazolam
- Bromonordiazepam
- Brotizolam
- Chlordiazepoxide
- Clobazam
- Clobromazolam
- Clonazepam
- Deschloroetizolam
- Desmethylflunitrazepam
- Delorazepam
- Diclazepam
- Ethylbromazolam
- Etizolam
- Flubromazepam
- Flubromazolam
- Flubrotizolam
- Fluclotizolam
- Fluetizolam
- Flunitrazepam (Rohypnol)
- Flunitrazolam
- Flurazepam
- Flutoprazepam
- Fosazepam
- Gidazepam
- Halazepam
- Medazepam
- Midazolam
- Nifoxipam
- Nimetazepam
- Nitrazepam
- Norflurazepam (Norfludiazepam)
- Phenazepam
- Phenazolam
- Prazepam
- Pyrazolam
- Triazolam
- Zaleplon
- Zolpidem (Ambien)
- Zopiclone

Gamma-aminobutyric acid type A receptor positive allosteric modulator (non-benzodiazepine site)
- Afloqualone
- Methaqualone
- SL-164 (Dicloqualone)
- Kava (Piper methysticum)
- Chloral Hydrate

Gamma-aminobutyric acid type A receptor positive allosteric modulator / Gamma-aminobutyric acid type A receptor agonist (at high concentration)
- Amobarbital
- Phenobarbital
- Thiopental
- Carisoprodol

Gamma-aminobutyric acid type A receptor agonist
- Gaboxadol (THIP)

Gamma-hydroxybutyrate receptor agonist / Gamma-aminobutyric acid type B receptor agonist
- GHB (Gamma-Hydroxybutyric Acid)
- GBL (Gamma-Butyrolactone)
- 1,4-BDO (1,4-Butanediol)
- Aceburic acid

Gamma-aminobutyric acid type B receptor agonist
- Baclofen
- 4-Fluorophenibut (F-Phenibut, 4-F-Phenibut, Fluorophenibut)
- GVL (Gamma-Valerolactone)

Voltage-gated calcium channel alpha-2-delta subunit ligand
- Gabapentin
- Pregabalin
- Mirogabalin

Gamma-aminobutyric acid type B receptor agonist / Voltage-gated calcium channel alpha-2-delta subunit ligand
- Phenibut

Gamma-aminobutyric acid type B receptor agonist / Gamma-aminobutyric acid type A receptor agonist (stereoselective)
- GABOB (γ-Amino-β-hydroxybutyric acid)

N-methyl-D-aspartate receptor agonist / Metabotropic glutamate receptor agonist / Prodrug to muscimol (gamma-aminobutyric acid type A receptor agonist)
- Ibotenic acid


#### **μ-Opioid receptor full agonist**

Morphine; Oxycodone; Hydrocodone; Hydromorphone; Desomorphine; Fentanyl; Acrylfentanyl; Alfentanil; 4-Methoxybutyrfentanyl; 4Cl-iBF; Lofentanil; Remifentanil; Furanylfentanyl; Etonitazene; Isotonitazene; Isotonitazepyne; Metonitazene; N-Desethylprotonitazene; Pronitazene; Acetorphine; Beta-meprodine

#### **μ-Opioid receptor full agonist / prodrug of R-4618**

Bezitramide

#### **Partial μ-opioid receptor agonist / κ-opioid receptor antagonist**

Buprenorphine

#### **κ-Opioid receptor agonist / μ-opioid receptor antagonist**

Butorphanol

#### **μ-Opioid receptor agonist with serotonin-norepinephrine reuptake inhibition / prodrug of O-desmethyltramadol**

Tramadol

#### **μ-Opioid receptor agonist with norepinephrine reuptake inhibition**

Tapentadol

#### **μ-Opioid receptor agonist / NMDA receptor antagonist / serotonin-norepinephrine transporter reuptake inhibition**

Methadone

#### **μ-Opioid receptor agonist / NMDA receptor antagonist / serotonin-norepinephrine transporter reuptake inhibition / prodrug of levorphanol**

Levomethorphan

#### **Peripherally-restricted μ-opioid receptor agonist**

Loperamide

#### **Partial μ-opioid receptor agonist with G-protein bias / κ-opioid receptor antagonist / δ-opioid receptor antagonist**

Kratom; Mitragynine; 7-Hydroxymitragynine; Mitragynine pseudoindoxyl; MGM-15

#### **μ-Opioid receptor agonist / prodrug of 6-monoacetylmorphine and morphine**

Heroin

#### **μ-Opioid receptor agonist / prodrug of morphine**

6-Monoacetylmorphine

#### **μ-Opioid receptor agonist / prodrug of dihydromorphine**

Acetyldihydrocodeine

#### **μ-Opioid receptor agonist / active metabolite of tramadol**

O-Desmethyltramadol

#### **μ-Opioid receptor agonist / prodrug of morphine via codiene / H1 histamine receptor antagonist via promethazine**

Lean

#### **G-protein-biased μ-opioid receptor agonists**

SR-17018; SR-14968

#### **μ-Opioid receptor agonists with limited data**

Methiodone; DPP-26

#### **Nociceptin receptor agonist with μ-opioid receptor affinity**

Spirochlorphine

#### **Opioid receptor agonist with limited data**

Cychlorphine